A critical discovery in cancer research is arising with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently inactivated in various types of malignancies, https://altbookmark.com/story23942338/vhh-fragments-revive-tumor-suppressor-p53-a-promising-hope-for-cancer-management